Category: Industry News
Haemonetics’ Strategic Acquisition of Attune Medical and the Future of Esophageal Cooling Technology
Haemonetics Corporation, a leading global medical technology firm, has announced its plans to acquire Attune Medical, a Chicago-based company known for its groundbreaking ensoETM® esophageal cooling ... Read More
Highlights from AAOS 2024: CytexOrtho, Triathlon Hinge, CartiHeal Agili-C, and more
The 2024 American Academy of Orthopaedic Surgeons (AAOS) meeting held in San Francisco was undeniably a standout event, particularly given the heightened anticipation following the prolonged impact of... Read More
The Dawn of Robotic-Assisted Shoulder Replacements: Zimmer Biomet’s ROSA® Shoulder System Receives FDA Clearance
In an impressive leap forward for medical technology, Zimmer Biomet, a colossus in the world of medical innovations, has recently shattered ceilings with its latest achievement: securing FDA approval ... Read More
Virtual and Augmented Reality Innovations Take Center Stage at AAOS 2024
AAOS 2024 marked an exceptional event, boasting a plethora of innovative devices, debut exhibitors, and cutting-edge technology. Among the array of advancements showcased during the event, virtual rea... Read More
How Can Data Be Used to Assist Mergers and Acquisitions?
Mergers and acquisitions are major decisions in an organization’s life. M&As can sometimes be a case of knowing when you know. These decisions, however, usually require data to support them.... Read More
Top Performers in the U.S. Central Station Monitors Market – Insights from iData’s MedSKU
CARESCAPE Central Station, retrieved from: https://www.gehealthcare.com/products/patient-monitoring/patient-monitors/carescape-central-station In iData’s comprehensive analysis of the U.S. Patie... Read More
Smith & Nephew Acquires CartiHeal: Details Behind the Deal
In a strategic move, Smith & Nephew is in the process of acquiring CartiHeal, a company specializing in off-the-shelf treatments for bone and cartilage lesions. This acquisition comes after a seri... Read More
Merck to Acquire Caraway Therapeutics in $610 Million Deal
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. have entered into a definitive agreement for Merck to acquire Caraway Therapeutics in a dea... Read More
